This is the authors' abstract. We don't add key points for this paper.
BIOMARKERSResearchers at the University of Michigan, Ann Arbor, have identified a metabolite in urine that they hope can be used to identify invasive prostate cancer at an early stage.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Jennifer Couzin (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: